Monitor the June 23, 2026, annual meeting for the re-election of all seven incumbent directors under the new declassified structure. The change in the CFO's award terms is a retention perk but does not materially alter the company's financial position.
Price Chart
Executive Summary
NRC Health filed an 8-K to announce a corporate name change from National Research Corporation to NRC Health, the declassification of its board of directors (requiring all directors to stand for annual election), and a change in equity award terms for its CFO allowing voting and dividend rights on unvested shares. The board resignations are procedural to facilitate declassification and not due to disagreement.
Key Facts
- Corporate name changed from National Research Corporation to NRC Health, effective April 15, 2026, with no change to the NRC ticker symbol.
- The board of directors was declassified, moving from a classified board with staggered three-year terms to an annual election cycle for all directors.
- Five directors (Donald Berwick, Trent Green, Michael Hays, Stephen Lockhart, John Nunnelly) submitted resignations effective prior to the June 23, 2026, annual meeting to facilitate the declassification; this is described as a procedural step, not a disagreement.
- The amended bylaws also establish a maximum of 12 board members and formally define the Chair of the Board position.
- The Compensation Committee amended CFO Shane Harrison's 172,000-share restricted stock award to permit voting and receipt of dividends on unvested shares.
Financial Impact
The name change and bylaw amendments are administrative and do not have a direct financial impact on the company's operations or financial statements.
Risk Factors
- Declassification increases shareholder influence but could make the company more vulnerable to activist campaigns or a hostile takeover.
- The resignation of five directors, while described as procedural, could be perceived negatively by the market if not clearly communicated.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-012850 |
| Exhibit: ex_943656.htm | 0001437749-26-012850 |
| Document: nrc20260409_8k.htm | 0001437749-26-012850 |
| Document: 0001437749-26-012850-index-headers.html | 0001437749-26-012850 |
| Document: 0001437749-26-012850-index.html | 0001437749-26-012850 |
| Document: 0001437749-26-012850.txt | 0001437749-26-012850 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 8-K | $22.45 | awaiting T+60 | — | $21.75 (−3.12%) |
Oct 19, 2026 8d ago | 8-K | $20.47 | awaiting T+60 | — | $21.75 (+6.25%) |
Apr 28, 2026 26w ago | 10-K/A | $16.54 $21.04 | ▲ +27.21% | ▲ +23.10% | $21.75 (+31.50%) |
Apr 28, 2026 26w ago | 8-K | $16.54 $21.04 | ▲ +27.21% | ▲ +23.10% | $21.75 (+31.50%) |
Apr 20, 2026 27w ago | 8-K | $17.18 $21.94 | ▲ +27.71% | ▲ +20.81% | $21.75 (+26.60%) |
Mar 5, 2026 33w ago | 8-K | $13.91 $20.25 | ▲ +45.56% | ▲ +34.26% | $21.75 (+56.34%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers